Crowdsourced ratings have driven increased performance transparency between consumers and suppliers. While many industries have benefitted from such transparency, crowdsourced ratings have struggled to scale in the healthcare domain. In theory, interoperability services offer an ideal setting for crowdsourced ratings: costs are high, performance is variable, and information asymmetries between provider organizations (customers) and vendors offering interoperability solutions exist. Via a Cooperative Agreement between the Office of the National Coordinator for Health Information Technology and University of California, San Francisco, we developed InteropSelect, a public website that allows crowdsourced ratings of interoperability service purchases. While we garnered broad engagement during the development process, the site failed to attract sufficient reviewers, which is fundamental to the success of crowdsourcing. Additional challenges included the lack of service commoditization that resulted in a complex rating form and lack of market dynamics that facilitated vendor engagement. Our lessons cast doubt on whether crowdsourcing and similar performance transparency efforts under the 21st Century Cures Act will succeed.

中文翻译：

---

为什么现实世界的健康信息技术性能透明度具有挑战性，即使每个人（声称）都想要它。

众包评级提高了消费者和供应商之间的绩效透明度。虽然许多行业都从这种透明度中受益，但众包评级在医疗保健领域一直难以扩大规模。理论上，互操作性服务为众包评级提供了理想的设置：成本高、性能多变，并且提供互操作性解决方案的提供商组织（客户）和供应商之间存在信息不对称。通过国家卫生信息技术协调员办公室与加州大学旧金山分校之间的合作协议，我们开发了 InteropSelect，这是一个公共网站，允许对互操作性服务购买进行众包评级。虽然我们在开发过程中获得了广泛的参与，该网站未能吸引足够的评论者，这是众包成功的基础。其他挑战包括缺乏服务商品化导致复杂的评级形式以及缺乏促进供应商参与的市场动态。我们的经验教训让人怀疑，根据《21 世纪治愈法案》，众包和类似的绩效透明度努力是否会成功。